Life sciences is too important to let promising innovation stall because the business side was underbuilt. Fractional ...

Cyber insurance has been around for a while, but it’s evolving quickly. Here’s why life sciences are so attractive — and how ...

Wave plans to initiate the Phase IIa multiple-dose portion of the INLIGHT trial this quarter, targeting participants with ...

Despite headwinds, the U.S. life sciences industry continues to yield impressive results, leveraging technology for earlier ...

Any AI tool. Any data source. Governed from the first query. Industrial teams want to use the best AI tools on their ...

AI governance is not merely a regulatory requirement, but also the strategic infrastructure that enables sustainable ...

US law firms highlight litigation profitability and client demand as driving forces behind a boom in lateral hires in the ...

Q1 2026 earnings call highlights: guidance reaffirmed, AI rollout traction, China momentum, IP rebound outlook, and LS&H sale ...

Angel investors are raising the bar with tighter criteria, backing strong teams, realistic markets and clear paths to exit ...

The developer behind San Diego’s ambitious waterfront research campus is being sued for fraud by one of its earliest investors. An entity affiliated with multifamily housing developer Aimco filed a ...

Life Sciences' $400 million commitment to Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) in March could be an example.

Million Financing Upfront with Up to an Additional $174 Million from Warrants Exercisable Within 20 Days of FDA Approval Transaction led by Frazier Life Sciences, TPG Life Sciences Innovations, venBio ...